Published in Infect Immun on November 01, 1975
RNA of mouse hepatitis virus. J Virol (1978) 4.27
Comparative analysis of RNA genomes of mouse hepatitis viruses. J Virol (1981) 2.30
Mouse hepatitis virus type 4 (JHM strains). induced fatal central nervous system disease. I. genetic control and murine neuron as the susceptible site of disease. J Exp Med (1981) 1.60
Persistence of mouse hepatitis virus A59 RNA in a slow virus demyelinating infection in mice as detected by in situ hybridization. J Virol (1984) 1.38
A pregnancy-specific glycoprotein is expressed in the brain and serves as a receptor for mouse hepatitis virus. Proc Natl Acad Sci U S A (1995) 1.34
Production by mixed lymphocyte cultures of a type II interferon able to protect macrophages against virus infection. Infect Immun (1977) 1.02
Ependymitis, leukoencephalitis, hydrocephalus, and thrombotic vasculitis following chronic infection by mouse hepatitis virus 3 (MHV 3). Acta Neuropathol (1982) 0.94
In vivo and in vitro models of demyelinating disease: endogenous factors influencing demyelinating disease caused by mouse hepatitis virus in rats and mice. Infect Immun (1982) 0.92
In vivo and in vitro models of demyelinating disease: activation of the adenylate cyclase system influences JHM virus expression in explanted rat oligodendrocytes. J Virol (1987) 0.90
Selective tropism of a neurotropic coronavirus for ependymal cells, neurons, and meningeal cells. J Virol (1986) 0.83
Brain Invasion by Mouse Hepatitis Virus Depends on Impairment of Tight Junctions and Beta Interferon Production in Brain Microvascular Endothelial Cells. J Virol (2015) 0.77
The pathogenesis of chronic viral hepatitis in the nude mouse and its influence on liver regeneration after partial hepatectomy. Br J Exp Pathol (1981) 0.75
MOUSE MACROPHAGES AS HOST CELLS FOR THE MOUSE HEPATITIS VIRUS AND THE GENETIC BASIS OF THEIR SUSCEPTIBILITY. Proc Natl Acad Sci U S A (1960) 6.27
The pathogenesis of Aleutian disease of mink. I. In vivo viral replication and the host antibody response to viral antigen. J Exp Med (1969) 3.98
Pathogenesis of demyelination induced by a mouse hepatitis. Arch Neurol (1973) 3.50
The choroid plexus in systemic lupus erythematosus. Ann Intern Med (1972) 2.69
Mechanism of demyelination in JHM virus encephalomyelitis. Electron microscopic studies. Acta Neuropathol (1973) 2.32
The pathogenesis of Aleutian disease of mink. 3. Immune complex arteritis. Am J Pathol (1973) 2.24
Hydrocephalus following viral infection: the pathology of aqueductal stenosis developing after experimental mumps virus infection. J Neuropathol Exp Neurol (1968) 1.75
Current concepts of amyloid. Adv Immunol (1972) 1.75
Genetic factors in resistance against virus infections. Arch Gesamte Virusforsch (1965) 1.74
Hydrocephalus in hamsters, ferrets, rats, and mice following inoculations with reovirus type I. I. Virologic studies. Lab Invest (1969) 1.23
The ultrastructure of vascular lesions in equine viral arteritis. Am J Pathol (1970) 1.14
Pathology of choroid plexus in spontaneous immune complex disease and chronic viral infections. Virchows Arch A Pathol Anat Histol (1974) 0.90
The fate of murine hepatitis virus (MHV-3) after intravenous injection into susceptible mice. Arch Gesamte Virusforsch (1967) 0.87
The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature (1996) 9.25
An examination of the cytotoxic effects of silica on macrophages. J Exp Med (1966) 8.42
Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet (1971) 7.98
Immunisation against heterologous type II collagen induces arthritis in mice. Nature (1980) 7.08
Role of contractile microfilaments in macrophage movement and endocytosis. Nat New Biol (1971) 4.82
Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia. J Exp Med (1989) 4.66
Macrophages and age-dependent resistance to Herpes simplex virus in mice. J Immunol (1970) 4.15
Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J (1997) 4.04
Membrane fusion. Biochim Biophys Acta (1973) 3.75
HIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J Exp Med (1997) 3.71
Possible importance of macrophage-derived mediators in acute malaria. Infect Immun (1981) 3.58
Selective effects of anti-macrophage serum, silica and anti-lymphocyte serum on pathogenesis of herpes virus infection of young adult mice. J Immunol (1970) 3.49
Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA. Proc Natl Acad Sci U S A (1988) 3.34
M-antiglobulins (rheumatoid-factor-like globulins) and other gamma-globulins in relation to tropical parasitic infections. Lancet (1966) 3.31
Requirement of thymus-dependent lymphocytes for potentiation by adjuvants of antibody formation. Nature (1971) 3.30
Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res (1992) 3.22
Identification of human mononuclear leucocyte populations by esterase staining. Clin Exp Immunol (1977) 3.12
Protection of mice against Babesia and Plasmodium with BCG. Nature (1976) 3.01
HIV enhancer activity perpetuated by NF-kappa B induction on infection of monocytes. Nature (1991) 2.97
Asbestos induces selective release of lysosomal enzymes from mononuclear phagocytes. Nature (1974) 2.86
The characterization of the promoter of the gene encoding the p50 subunit of NF-kappa B indicates that it participates in its own regulation. EMBO J (1992) 2.86
Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection. J Exp Med (1977) 2.84
Extensive prolongation of rabbit kidney allograft survival after short-term cyclosporin-A treatment. Lancet (1978) 2.80
Changes in cellular enzyme levels and extracellular release of lysosomal acid hydrolases in macrophages exposed to group A streptococcal cell wall substance. J Exp Med (1974) 2.72
Effects of antilymphocyte serum on virus oncogenesis. Proc Soc Exp Biol Med (1968) 2.63
Effects of activated complement components on enzyme secretion by macrophages. Immunology (1976) 2.63
Babesia microti and Plasmodium berghei yoelii infections in nude mice. Nature (1974) 2.55
Antibody responses to antigenic determinants of influenza virus hemagglutinin. I. Thymus dependence of antibody formation and thymus independence of immunological memory. J Exp Med (1974) 2.54
An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity. J Immunol Methods (1986) 2.50
HIV blocked by chemokine antagonist. Nature (1996) 2.50
Potentiation by silica of the growth of Mycobacterium tuberculosis in macrophage cultures. Br J Exp Pathol (1968) 2.48
Interactions of antibodies, complement components and various cell types in immunity against viruses and pyogenic bacteria. Transplant Rev (1974) 2.45
Host defenses against influenza virus: the role of anti-hemagglutinin antibody. J Immunol (1975) 2.44
Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm. J Cell Sci (1997) 2.44
Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection. J Immunol (1976) 2.34
Stromal cell-derived factor-1alpha associates with heparan sulfates through the first beta-strand of the chemokine. J Biol Chem (1999) 2.32
HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene. Lancet (1998) 2.32
Physico-chemical properties of silica in relation to its toxicity. Nature (1966) 2.32
Quantitative histological studies on the aged human brain. I. Senile plaques and neurofibrillary tangles in "normal" patients. Acta Neuropathol (1970) 2.30
Lymphocytes binding human thyroglobulin in healthy people and its relevance to tolerance for autoantigens. Lancet (1973) 2.28
Protection of mice against Babesia spp. and Plasmodium spp. with killed Corynebacterium parvum. Parasitology (1977) 2.28
Antibody responses to antigenic determinants of influenza virus hemagglutinin. II. Original antigenic sin: a bone marrow-derived lymphocyte memory phenomenon modulated by thymus-derived lymphocytes. J Exp Med (1974) 2.25
Mechanisms by which activated macrophages inhibit lymphocyte responses. Immunol Rev (1978) 2.24
A dominant negative protein kinase C zeta subspecies blocks NF-kappa B activation. Mol Cell Biol (1993) 2.20
Nature of the effector cells responsible for antibody-dependent cell-mediated killing of Cryptococcus neoformans. Infect Immun (1976) 2.16
Heterophile antibodies, M-antiglobulins and immunoglobulins in experimental trypanosomiasis. Clin Exp Immunol (1969) 2.16
The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. J Clin Invest (1990) 2.08
A role of macrophages in the stimulation of immune responses by adjuvants. J Immunol (1969) 2.06
Role of contractile microfilaments in the release of histamine from mast cells. Nature (1972) 1.99
Role of lysosomes and of cell membranes in photosensitization. Nature (1966) 1.91
Use of cyclosporin A in allogeneic bone marrow transplantation in the rat. Nature (1979) 1.90
A microtransfection method using the luciferase-encoding reporter gene for the assay of human immunodeficiency virus LTR promoter activity. Gene (1990) 1.90
The inhibition of phagocytosis and facilitation of exocytosis in rabbit polymorphonuclear leukocytes by cytochalasin B. Lab Invest (1973) 1.89
The role of cell-mediated immune responses in resistance to malaria, with special reference to oxidant stress. Annu Rev Immunol (1983) 1.88
Antibacterial antibodies in rectal and colonic mucosa in ulcerative colitis. Lancet (1971) 1.88
Stromal-cell derived factor is expressed by dendritic cells and endothelium in human skin. Am J Pathol (1999) 1.88
Tumor necrosis factor stimulates transcription of HIV-1 in human T lymphocytes, independently and synergistically with mitogens. J Immunol (1989) 1.87
Histopathological classification of nonantral gastric endocrine growths in man. Digestion (1988) 1.85
Ability of activated complement components to induce lysosomal enzyme release from macrophages. Nature (1976) 1.85
Association of brain damage with therapeutic abortion induced by amniotic-fluid replacement: report of two cases. Br Med J (1966) 1.83
Mineral fibers: chemical, physicochemical, and biological properties. Adv Pharmacol Chemother (1975) 1.83
Dual role of tumor necrosis factor-alpha in angiogenesis. Am J Pathol (1992) 1.82
Zymosan-induced arthritis: a model of chronic proliferative arthritis following activation of the alternative pathway of complement. Arthritis Rheum (1977) 1.82
Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation. Immunology (1977) 1.82
Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells. J Exp Med (1998) 1.81
Tissue thromboplastin activity of isolated human monocytes. Thromb Haemost (1978) 1.81
Pathogenesis of syringomyelia. Lancet (1972) 1.79
Mode of action of adjuvants: effects on antibody responses to macrophage-associated bovine serum albumin. J Immunol (1970) 1.79
Immune responses in mice with murine leprosy. Clin Exp Immunol (1970) 1.79
Genetic factors in resistance against virus infections. Arch Gesamte Virusforsch (1965) 1.74
Role of macrophages and antibody in resistance of mice against yellow fever virus. J Immunol (1971) 1.71
The role of thymus-dependent immunity in Mycoplasma pulmonis infections of mice. J Med Microbiol (1972) 1.69
Mechanisms of endocytosis and exocytosis. Symp Soc Exp Biol (1974) 1.69
The role of antibody and host cells in the resistance of mice against infection by coxsackie B-3 virus. J Gen Virol (1973) 1.68
Role of T lymphocytes in recovery from murine cytomegalovirus infection. Infect Immun (1977) 1.68
Unresponsiveness to self antigens. Lancet (1971) 1.67
Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion. Scand J Immunol (1991) 1.67
Interferons as macrophage-activating factors. III. Preferential effects of interferon-gamma on the interleukin 1 secretory potential of fresh or aged human monocytes. J Immunol (1985) 1.65
Immune complexes induce selective release of lysosomal hydrolases from macrophages. Nature (1974) 1.64
The role of microfilaments and microtubules in cell movement, endocytosis and exocytosis. Ciba Found Symp (1973) 1.61
Monoclonal antibodies to human recombinant interleukin 1 (IL 1)beta: quantitation of IL 1 beta and inhibition of biological activity. J Immunol (1987) 1.61
Pathogenesis of the chronic inflammatory lesion induced by group A streptococcal cell walls. Lab Invest (1974) 1.60
Inhibition of protein kinase C zeta subspecies blocks the activation of an NF-kappa B-like activity in Xenopus laevis oocytes. Mol Cell Biol (1993) 1.60
Serum containing tumor necrosis factor is cytotoxic for the human malaria parasite Plasmodium falciparum. Infect Immun (1983) 1.60
Immunity and immunopathology in virus infections. Ann Inst Pasteur (Paris) (1972) 1.60
Participation of mononuclear phagocytes in chronic inflammatory diseases. J Reticuloendothel Soc (1974) 1.59
RS-61443--a new, potent immunosuppressive agent. Transplantation (1991) 1.57
On the role of mononuclear phagocytes in immunity against viruses. Prog Med Virol (1974) 1.55
Quantitative histological studies on the aged human brain. II. Senile plaques and neurofibrillary tangles in senile dementia (with an appendix on their occurrence in cases of carcinoma). Acta Neuropathol (1970) 1.55
Atypical teratomas of the pineal and hypothalamus. J Pathol Bacteriol (1966) 1.54
Role of mononuclear infiltrating cells in pathogenesis of hepatitis. Lancet (1978) 1.52
Role of IFN-gamma-induced indoleamine 2,3 dioxygenase and inducible nitric oxide synthase in the replication of human cytomegalovirus in retinal pigment epithelial cells. J Immunol (1999) 1.50
Demyelinating peripheral neuropathy and liver disease. Lancet (1967) 1.48
Differences in susceptibility of various mouse strains to haemoprotozoan infections: possible correlation with natural killer activity. Parasite Immunol (1980) 1.48
Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies. J Immunol Methods (1989) 1.48
Observations on thymectomy and carcinogenesis. Cancer Res (1967) 1.48
Redox status of cells influences constitutive or induced NF-kappa B translocation and HIV long terminal repeat activity in human T and monocytic cell lines. J Immunol (1992) 1.48
Correlation of persistent mouse hepatitis virus (MHV-3) infection with its effect on mouse macrophage cultures. Arch Virol (1976) 1.48